The Food and Drug Administration’s expedited approval of drugs like the blood thinner Pradaxa may be endangering U.S. consumers, according to a new column in the Journal of the American Medical Association.
“Although enabling new drugs with a favorable benefit-to-harm balance to become available to patients more rapidly is a » […]
Original post by http://lawyersusaonline.com/blog/2012/09/17/fdas-fast-tracking-of-drugs-called-risky/
Report bad drivers!